XML 110 R91.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule II: Condensed Combined Financial Information of Registrant - Statement of Cash Flows (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:                      
Net loss $ (133,300,000) $ (85,200,000) $ (38,900,000) $ (105,600,000) $ (85,200,000) $ (100,200,000) $ (47,300,000) $ (49,700,000) $ (363,000,000.0) $ (282,400,000) $ (69,100,000)
Adjustments to reconcile net loss to net cash used in operating activities:                      
Share-based compensation                 3,700,000 1,400,000 100,000
Tender offer                 25,100,000 8,600,000 0
Depreciation and amortization, net                 15,600,000 4,900,000 600,000
SAFE fair value adjustment                 0 11,200,000 0
Warrants fair value adjustment                 54,700,000 0 0
Paid-in kind interest expense                 9,100,000 800,000 0
Changes in operating assets and liabilities:                      
Other assets                 (21,700,000) (3,700,000) (2,700,000)
Accounts payable and accrued expenses                 18,200,000 19,200,000 9,000,000.0
Other liabilities                 2,100,000 2,700,000 (300,000)
Net cash used in operating activities                 (287,200,000) (127,200,000) (26,100,000)
Cash flows from investing activities:                      
Purchases of investments                 (158,400,000) (138,100,000) (40,300,000)
Proceeds from maturities, call and pay downs of investments                 42,500,000 36,200,000 19,200,000
Capitalization of internally developed software                 (5,400,000) (5,500,000) (2,300,000)
Purchases of fixed assets                 (1,800,000) (6,600,000) (1,200,000)
Net cash used in investing activities                 (114,100,000) (114,000,000.0) (20,600,000)
Cash flows from financing activities:                      
Proceeds from issuance of common stock from IPO and concurrent private placements, net of issuance costs                 1,098,100,000 0 0
Proceeds from issuance of preferred stock, net of issuance costs                 0 349,600,000 150,800,000
Proceeds from debt and warrants issuance, net of issuance costs                 12,000,000.0 189,500,000 0
Repayments of long-term debt                 (13,500,000) (15,500,000) 0
Proceeds from SAFE                 0 10,000,000.0 0
Purchases of treasury stock                 (200,000) 0 0
Net cash provided by financing activities                 1,098,500,000 535,500,000 150,900,000
Net increase in cash, cash equivalents and restricted cash                 697,200,000 294,300,000 104,200,000
Cash, cash equivalents and restricted cash at beginning of year       416,600,000       122,300,000 416,600,000 122,300,000 18,100,000
Cash, cash equivalents and restricted cash at end of year 1,113,800,000       416,600,000       1,113,800,000 416,600,000 122,300,000
Supplemental disclosures:                      
Interest paid                 4,500,000 4,300,000 800,000
Federal income taxes paid                 0 0 0
Leasehold improvements - non-cash                 0 1,500,000 2,600,000
Conversion of SAFE to preferred stock - noncash                   11,200,000  
Conversion of preferred stock to common stock - non-cash                 560,400,000 0 0
Conversion of warrants to common stock - non-cash                 75,000,000.0 0 0
Purchases of treasury stock - non-cash                 500,000 0 0
Parent Company                      
Cash flows from operating activities:                      
Net loss                 (363,000,000.0) (282,400,000) (69,100,000)
Adjustments to reconcile net loss to net cash used in operating activities:                      
Share-based compensation                 3,700,000 1,400,000 100,000
Tender offer                 25,100,000 8,600,000 0
Depreciation and amortization, net                 11,800,000 3,500,000 200,000
Change in equity in subsidiaries                 228,900,000 242,500,000 68,200,000
SAFE fair value adjustment                 0 11,200,000 0
Warrants fair value adjustment                 54,700,000 0 0
Paid-in kind interest expense                 9,100,000 800,000 0
Changes in operating assets and liabilities:                      
Other assets                 (15,500,000) (1,200,000) (1,100,000)
Accounts payable and accrued expenses                 3,800,000 4,900,000 (400,000)
Other liabilities                 2,100,000 600,000 300,000
Intercompany, net                 (23,600,000) (7,200,000) (11,000,000.0)
Net cash used in operating activities                 (62,900,000) (17,300,000) (12,800,000)
Cash flows from investing activities:                      
Purchases of investments                 (500,000) 0 (9,800,000)
Proceeds from maturities, call and pay downs of investments                 0 1,700,000 8,200,000
Capitalization of internally developed software                 (5,400,000) (3,900,000) 0
Purchases of fixed assets                 (1,800,000) (6,500,000) (1,000,000.0)
Investment in subsidiaries                 (201,900,000) (333,000,000.0) (95,000,000.0)
Net cash used in investing activities                 (209,600,000) (341,700,000) (97,600,000)
Cash flows from financing activities:                      
Proceeds from issuance of common stock from IPO and concurrent private placements, net of issuance costs                 1,098,100,000 0 0
Proceeds from exercise of stock options                 2,100,000 1,900,000 100,000
Proceeds from issuance of preferred stock, net of issuance costs                 0 349,600,000 150,800,000
Proceeds from debt and warrants issuance, net of issuance costs                 12,000,000.0 189,500,000 0
Repayments of long-term debt                 (13,500,000) (15,500,000) 0
Proceeds from SAFE                 0 10,000,000.0 0
Purchases of treasury stock                 (200,000) 0 0
Net cash provided by financing activities                 1,098,500,000 535,500,000 150,900,000
Net increase in cash, cash equivalents and restricted cash                 826,000,000.0 176,500,000 40,500,000
Cash, cash equivalents and restricted cash at beginning of year       $ 218,100,000       $ 41,600,000 218,100,000 41,600,000 1,100,000
Cash, cash equivalents and restricted cash at end of year $ 1,044,100,000       $ 218,100,000       1,044,100,000 218,100,000 41,600,000
Supplemental disclosures:                      
Interest paid                 4,500,000 4,300,000 800,000
Federal income taxes paid                 0 0 0
Leasehold improvements - non-cash                 0 1,500,000 2,600,000
Conversion of SAFE to preferred stock - noncash                 0 11,200,000 0
Conversion of preferred stock to common stock - non-cash                 560,400,000 0 0
Conversion of warrants to common stock - non-cash                 75,000,000.0 0 0
Purchases of treasury stock - non-cash                 $ 500,000 $ 0 $ 0